Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06970977 · ClinicalTrials.gov registry record

CRS Questionnaire Validation Project

A clinical trial of Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps, sponsored by The European Forum for Research and Education in Allergy and Airway Diseases.

Recruiting
Registry status
1,000
Enrollment target
20
Study locations

NCT06970977: Recruiting study of Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps, sponsored by The European Forum for Research and Education in Allergy and Airway Diseases.

NCT06970977 is a study of Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps that is actively recruiting participants, run by The European Forum for Research and Education in Allergy and Airway Diseases. The registered enrollment target is 1,000 participants. The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06970977, a study of Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps, is actively recruiting participants, sponsored by The European Forum for Research and Education in Allergy and Airway Diseases.

RECRUITING
Registry status
1,000 participants
Enrollment target
20
Study locations

Study Summary

The 'CRS validation project' consists of a joint effort of 32 medical centers in Europe, the USA, and South Africa to carry out the validation of 2 novel questionnaires designated to measure self-perceived severity and control of Chronic Rhinosinusitis (with or without nasal polyps). This study will validate translated versions of the same set of questionnaires simultaneously in the centers involved after recruiting a total of 1000 patients, while data collection, statistical analysis, and creation of the study report will be carried out by the statistical department of the University of Leuven. Patients will be recruited from the regular ENT practice of their hospital to minimize the complexity of the study.

Primary Outcome

Validation of a questionnaire based on similar questionnaires already approved for use in other airway diseases. The aim to measure the current perceived status of a patient with chronic rhinosinusitis in terms of control and severity. A new questionnaire will be tested and compared with current tools. For this purpose, a set of questionnaires has been developed including the EPOS criteria for chronic rhinosinusitis, the SNOT-22, the patient global assessment tool and the VAS scores, among othe

Study Locations (20)

Other

  • UZ Gent - Ghent
  • UZ Leuven - Leuven
  • St. Michael's Hospital - Toronto
  • Univ of Copenhagen - Copenhagen
  • HNO-Klinik, Universitätsklinikum Düsseldorf - Düsseldorf
  • Univ Munich - Munich
  • University General Hospital of Heraklion - Heraklion
  • U. Aristotle - Thessaloniki
  • Univ Hospital Roma - Roma
  • Univ Amsterdam - Amsterdam
  • Alrijne Zorggroep - Leiden
  • University of Oradea - Oradea
  • Ahmed Alkhadi Hospital - Durban
  • Hospital Clínico Universitario de Compostela - A Coruña
  • Hospital Clinic Barcelona - Barcelona

California

  • UCLA Santa Monica Medical Center - Santa Monica

Illinois

  • Northwestern University Feinberg School of Medicine - Chicago

Massachusetts

  • Brigham Sinus Center at Brigham and Women's Hospital - Boston

Pennsylvania

  • Thomas Jefferson University Hospital - Philadelphia

Virginia

  • Eastern Virginia Medical School - Virginia City

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2024-09-01
Est. Completion 2026-09-30

What NCT06970977 shows while recruiting

NCT06970977 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps appearing as the primary indexed condition, and to 0 interventions.

NCT06970977 names 20 study sites across 6 states, led by Other, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT06970977 about?

NCT06970977 is a clinical study titled "CRS Questionnaire Validation Project". The 'CRS validation project' consists of a joint effort of 32 medical centers in Europe, the USA, and South Africa to carry out the validation of 2 novel questionnaires designated to measure self-perceived severity and control of Chronic Rhinosinusitis (with or without nasal polyps). This study wil...

What is the current status of trial NCT06970977?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-09-01. Estimated completion is 2026-09-30.

What conditions does trial NCT06970977 study?

This clinical trial studies the following conditions: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps.

Who is sponsoring clinical trial NCT06970977?

This trial is sponsored by The European Forum for Research and Education in Allergy and Airway Diseases, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06970977 being conducted?

This trial has 20 study locations across California, Illinois, Massachusetts, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06970977, the US trial registry maintained by the National Library of Medicine. NCT06970977 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.